Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dingkundan Combined With Oral Contraceptives for PCOS
NCT05872425Completed
- Sponsor
- Guangdong Women and Children Hospital
- Start
- Feb 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dingkundan in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Guangdong Women and Children Hospital. Primary endpoints: Serum androgen at 3 months, Free testosterone at 3 months and 2 more. Started Feb 2023; status: completed.
02
Drugs
dingkundan
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05872425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05872425.